Effects of a Combined Program of Pelvic Floor Muscle Training and Yoga
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Pelvic Floor Muscle Training (PFMT) and yoga.
- Who it may be relevant to
- Registry conditions: Genitourinary Symptoms, Sexual Function, Quality of Life. Basic parameters: 20 years — 60 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effects of a Combined Program of Pelvic Floor Muscle Training and Yoga on Relieving Genitourinary Symptoms, and Improving Sexual Function and Quality of Life in Asian Women With Breast Cancer
Overview
This study aims to examine the effects of Pelvic Floor Muscle Training (PFMT) combined with yoga on relieving genitourinary symptoms, symptom-related quality of life, and improving sexual function in women with breast cancer. This study is a parallel randomized study with two groups. Women will be assigned to the experimental or control group by using the block randomization method. The experimental group will receive regular care and a 12-week program of PFMT and yoga. The control group will receive regular care. We collect relevant data from both groups at baseline and 4, 8, 12, and 24 weeks after baseline during the study period.
Detailed description
This study will be conducted with the approval obtained from the Institutional Review Board (IRB) of MacKay Memorial Hospital. This parallel-two-group randomized experimental study including an experimental group and a control group examines the effects of pelvic floor muscle training (PFMT) combined with yoga on genitourinary symptoms, symptom-related quality of life, and sexual function. A sample of women with breast cancer experiencing ≥1 genitourinary symptom(s) will be recruited and assigned to an experimental group or a control group by using the block randomization method. The experimental group will receive regular care and a 12-week program of PFMT and yoga. We will provide the experimental group with 12 days of online group practice sections of PFMT and yoga (weekly 60-minute practice incudes yoga 40 minutes, PFMT 15 minutes, and reflection 5 minutes). We expect them to perform 36 days of home-based practice of PFMT and yoga with 3 days/week of yoga for 40 minutes and PFMT for 15 minutes. The control group will receive regular care and relevant educational materials after data collection. Information will be collected at five time points: baseline and 4, 8, 12, and 24 weeks after baseline. Generalized estimating equation procedures will be used to examine the effects of the intervention. We hypothesized that the experimental group will display more significant improvements in genitourinary symptoms, symptom-related influences, and sexual function than those shown in the control group.
Interventions
- Behavioral Pelvic Floor Muscle Training (PFMT) and yoga
The experimental group participants will be instructed to perform the practice session four days a week. The four days per week practice times (PFMT 15 minutes/day; yoga 40 minutes/day.) will result in weekly practice times for pelvic floor muscle training (PFMT) of 60 minutes and for yoga of ≥150 minutes.
Primary outcome measures
- Vulvovaginal Symptoms [Time frame: Baseline]
- Vulvovaginal Symptoms [Time frame: 4 weeks after baseline]
- Vulvovaginal Symptoms [Time frame: 8 weeks after baseline]
- Vulvovaginal Symptoms [Time frame: 12 weeks after baseline]
- Vulvovaginal Symptoms [Time frame: 24 weeks after baseline]
Secondary outcome measures (5)
- Urinary symptoms [Time frame: Baseline]
- Urinary symptoms [Time frame: 4 weeks after baseline]
- Urinary symptoms [Time frame: 8 weeks after baseline]
- Urinary symptoms [Time frame: 12 weeks after baseline]
- Urinary symptoms [Time frame: 24 weeks after baseline]
Eligibility criteria
Inclusion criteria
- Women aged 20-60 years
- Women with a confirmed diagnosis of breast cancer (Stages I-III) for ≥3 months
- Women who experience ≥1 genitourinary symptom(s)
Exclusion criteria
- Women with other types of cancer diagnoses (e.g., endometrial cancer and ovarian cancer)
- Women with inadequately managed chronic conditions (e.g., an individual with diabetes having HbA1c level >7%)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Taiwan · 1 center
- MacKay Memorial Hospital — Taipei
Identifiers
NCT: NCT06411041 · 24MMHIS120e